| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Nilotinib |
| Brand | Tasigna® |
| Indication | For the newly diagnosed Chronic Phase Philadelpha Chromosone positive CML. |
| Assessment Process | |
| Rapid review commissioned | 06/10/2010 |
| Rapid review completed | 22/10/2020 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation Recommended |